IMCI Pharmaceuticals

A pharmaceutical company developing novel and patented cannabis-based medicines to treat neuropathic pain and chronic indications.

Pharmaceuticals
Active
Pre-Funding Gan Yavne, Israel Founded 2018
Last updated 2026-09-03
Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
9
HQ
Gan Yavne, Israel
Sector
Pharmaceuticals

About

IMCI is a pharmaceutical company that develops innovative pharma-grade and formulated cannabis-based medications to treat chronic indications with a global reach. IMCI has developed a precise and effective dose together with an easy-to-use administration, suitable for any patient population at any time and place via its iCann medicinal cannabis platform. IMCI research and development is based on an Israeli leading academic research institution in collaboration with established Israeli pharmaceutical providers which together with its team members, possess a proven track record in developing innovative cannabis-based medications. The company aims to become a leading pharmaceutical company that will develop pharmaceutical and medicinal cannabis-based novel medicines to treat prevalent health conditions at an affordable price. IMCI views itself as an R&D startup and is focused on creating nanoparticles out of cannabis for more effective delivery of cannabinoids.

Offices

Gan Yavne, Israel · HQ / main office
Show all offices (1 more)
  • United Kingdom

Q&A

What is IMCI Pharmaceuticals' primary focus?
IMCI Pharmaceuticals is a pharma-grade medical cannabis company focused on redefining patient care through science, safety, and precision.
What is IMCI Pharmaceuticals' proprietary technology?
IMCI Pharmaceuticals utilizes its proprietary NanoVATE™ drug-delivery platform to enhance cannabinoid bioavailability.
What products does IMCI Pharmaceuticals offer?
IMCI Pharmaceuticals offers the iCann product line, which includes iCann Fast, iCann Oral, and iCann LA, designed for fast, accurate, and long-lasting relief.
Where is IMCI Pharmaceuticals expanding its operations?
IMCI Pharmaceuticals is expanding its operations across Europe, Israel, and the U.S.
When was IMCI Pharmaceuticals founded?
IMCI Pharmaceuticals was founded in December 2018.
How many employees does IMCI Pharmaceuticals have?
IMCI Pharmaceuticals has 1-10 employees.
What is the current funding stage of IMCI Pharmaceuticals?
IMCI Pharmaceuticals is currently in the Pre-Funding stage.
Does IMCI Pharmaceuticals hold any patents?
Yes, IMCI Pharmaceuticals holds 1 patent.

Team · 11

Alon Hershkovitz
Founder · Chief Executive Officer, Co-Founder
Avi Yakobovich
Founder · VP Regulatory Affairs, Co-Founder
Hagay Segev
Founder · Head of Project Management, Co-Founder
David Blum
Chief Technology Officer
Jonathan E. Friedman, Ph.D.
Chief Research & Development Officer
Gershon Ravid
Chief Operating Officer
Jeff Wechsler
USA Business Development & Sales
Prof. Igor Spigelman, PhD
Scientific Development Specialist Advisor
Dr. Arnon Aharon
Clinical Development Specialist Advisor
Prof. Abraham J. Domb, Ph.D.
Formulation Development Specialist Advisor
Joseph J Morgan, M.D., AACM
Medical Director Specialist Advisor

Sectors & technology

Primary sector
Pharmaceuticals
Technologies
Target customers

Highlights

1 PatentsVerified

Tags

oncologydrug-developmentcannabispain-relieftreatmentspain-freetherapeuticsdrug-deliverydrug-discoverypharmaceuticalsbiopharmaceuticalmedical-cannabisbiotechnologycancerchronic-painpharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteimci-bv.com
LinkedInlinkedin.com/company/imci-pharmaceuticals

Identifiers & details

Legal nameIMCI Medicine Development Ltd
Founded2018
Employees (exact)9
OfficesUnited Kingdom

Radar intelligence

Web history (Wayback)

Domainimci-bv.com

Certificate / subdomain footprint

Subdomains1